Adams “edible film” OTCs
This article was originally published in The Tan Sheet
Executive Summary
Adams Respiratory Therapeutics will develop oral thin-film drug delivery OTC and pharmaceutical respiratory products under a licensing agreement with drug delivery firm MonoSol Rx, the company announces March 27. Under the deal, Adams receives an exclusive, royalty-bearing non-transferable license from MonoSol to develop and market two or more respiratory products in North America. Under a separate agreement, MonoSol will manufacture and supply the finished products. MonoSol will complete product development, while Adams will perform all clinical development, regulatory submissions and commercial operations. Financial terms of the deal were not disclosed, but Adams notes MonoSol will receive payments in exchange for completing pre-defined development milestones. Leiner launched several OTC drug and dietary supplement products in orally dissolving strips in 2005 under a deal with MonoSol (1"The Tan Sheet" Aug. 15, 2005, p. 8)...You may also be interested in...
Leiner, MonoSol Deal Brings Oral Strip Technology To Private Label Market
HBW Executive Decisions: Perrigo Americas, Nutraceutical International Helm Changes, ABC Farnsworth Award, More
Myos Rens hires Eric LeGrand as special advisor for sports nutrition; Perrigo Consumer Americas chief Jeff Needham will be succeeded by Rich Sorota; Nutraceutical International appoints Monty Sharma to replace Chad Clawson at the helm; American Botanical Council’s Farnsworth Award goes to Rachel Mata; and Herbalife’s John Agwunobi will be chairman as well as CEO.
Philips Expert Urges Device Makers: Update Quality Systems To Conform To Revised Risk Standard ISO 14971
It’s time for manufacturers to begin adopting the new 2019 version of ISO 14971, the international standard for risk management widely used by industry. But firms need to do more work than just changing the date on risk-related procedures and documents to “2019,” says Jos Van Vroonhoven, a senior manager at Philips Healthcare who was intimately involved with the standard’s redo. From conducting gap assessments to creating cross-functional teams, both Van Vroonhoven and longtime industry expert Don Powers tell Medtech Insight how firms can keep their quality systems up-to-date to conform to ISO 14971:2019.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: